ArticleBiology2026
Exploring the Phosphoregulatory Network of Human Sucrose Non-Fermenting 1-Related Kinase.
Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sucrose non-fermenting 1-related kinase (SNRK) is an understudied serine/threonine kinase of the CAMKL family, known for its role in metabolic regulation and cell signaling. Despite its emerging relevance in various biological processes and diseases, the phosphoregulatory landscape of human SNRK (valid substrates or role of its phosphosites) remains unexplored and demands robust, large-scale, data-oriented approaches to predict the potential substrates. A comprehensive analysis of global human phosphoproteomics datasets was performed to systematically identify class I phosphosites on SNRK, along with their predicted upstream kinases, potential downstream substrates, and coregulated phosphoproteins. Our analysis resulted in the identification of 33 dark SNRK phosphosites, of which 19 were differentially regulated across an array of experimental conditions. Among them, S518 and S569, outside their kinase domain, were the most frequently regulated and co-occurred phosphosites under diverse conditions. Notably, S569 is predicted as a candidate autophosphorylation site of SNRK. In these contexts, coregulation analysis of proteins and their phosphorylation sites suggested associations of phospho-SNRK in cell cycle progression, chromatin organization, and DNA replication. Uncovering candidate upstream kinases and potential substrates for prioritized validation, this study provides the first comprehensive phosphoproteomic map of SNRK, serving as a foundation for future investigations into its signaling network associations and therapeutic approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.